
LAKEFRONT BIOTHERAPEUTIC-ADR
LKFT · NASDAQ
Updated at 2026-10-15 07:53:16
- Today's High
- $29.45
- Today’s Low
- $28.50
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $28.67
- Previous Close
- $29.40
- Volume
- 226.58K
- Market Cap
- $1.72B
- P/E Ratio
- 2.89X
- EPS
- $9.04
Previous Day Range
52-Week Range
Company Overview
- Sector
- HEALTHCARE
- Industry
- Biotechnology
- Sub-industry
- BIOTECHNOLOGY
- Headquarters
- SCHALIENHOEVEDREEF 20 T, MECHELEN, BELGIUM, 2800
- Country
- BE
- Listing Date
- 2005-05-06
- Fiscal Year End
- December
- Shares Outstanding
- 65.9M
- CIK
- 0001421876
- Website
- www.glpg.com
Lakefront Biotherapeutics NV (LKFT) is an innovative biopharmaceutical company focused on addressing significant unmet medical needs in oncology and infectious diseases through its proprietary therapies. With a robust pipeline that integrates advanced biologics and small molecules, the company is committed to enhancing patient outcomes and advancing its clinical programs. Lakefront prioritizes the formation of strategic partnerships to amplify its research capabilities and expand market presence, positioning itself as a future leader in the biotherapeutics space. The company’s dedication to scientific excellence ensures a patient-centric approach in developing transformative healthcare solutions.
Financial Metrics
Revenue
2026-06-30
$12.11M
2026-03-31
$6.48M
2025-12-31
$900.82M
2025-09-30
$71.16M
Operating Expenses
2026-06-30
$20.97M
2026-03-31
$65.38M
2025-12-31
$141.56M
2025-09-30
$101.98M
Net Income
2026-06-30
$2.1M
2026-03-31
$14.49M
2025-12-31
$782.14M
2025-09-30
-$202.11M
Net Profit Margin
2026-06-30
17.39%
2026-03-31
223.6%
2025-12-31
86.82%
2025-09-30
-284.01%
Earnings Per Share
2026-06-30
$0.03
2026-03-31
$0.21
2025-12-31
$12.27
2025-09-30
$-0.18
Earnings Before Interest, Taxes, Depreciation, and Amortization
2026-06-30
-$40.45M
2026-03-31
$13.95M
2025-12-31
$560.49M
2025-09-30
$2.41M
Effective Tax Rate
2026-06-30
6.36%
2026-03-31
0.5%
2025-12-31
0.08%
2025-09-30
7.9%
| Item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| Revenue | $12.11M | $6.48M | $900.82M | $71.16M |
| Operating Expenses | $20.97M | $65.38M | $141.56M | $101.98M |
| Net Income | $2.1M | $14.49M | $782.14M | -$202.11M |
| Net Profit Margin | 17.39% | 223.6% | 86.82% | -284.01% |
| Earnings Per Share | $0.03 | $0.21 | $12.27 | $-0.18 |
| Earnings Before Interest, Taxes, Depreciation, and Amortization | -$40.45M | $13.95M | $560.49M | $2.41M |
| Effective Tax Rate | 6.36% | 0.5% | 0.08% | 7.9% |
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.